内蒙古民族大学学报：自然科学版
內矇古民族大學學報：自然科學版
내몽고민족대학학보：자연과학판
Journal of Inner Mongolia University for the Nationalities(Natural Sciences)
2012年
2期
222-223
,共2页
蚓激酶%IgA肾病%肾功能
蚓激酶%IgA腎病%腎功能
인격매%IgA신병%신공능
Lumbrokinase%IgA nephropathy%Kidney function
目的：探讨蚓激酶治疗IgA肾病（IgAN）的临床效果和安全性．方法：将30例在本院住院治疗及门诊治疗的IgA肾病患者随机分为观察组和对照组，对照组给予基础治疗，观察组在基础治疗上加用蚓激酶，观察两组治疗效果．结果：与治疗前相比，两组治疗后尿蛋白、肾功能均有所改善（P〈0．05）；与对照组相比，观察组患者上述指标改善更明显（P〈0．05）．结论：蚓激酶治疗IgA。肾病疗效确切，且无严重不良反应．
目的：探討蚓激酶治療IgA腎病（IgAN）的臨床效果和安全性．方法：將30例在本院住院治療及門診治療的IgA腎病患者隨機分為觀察組和對照組，對照組給予基礎治療，觀察組在基礎治療上加用蚓激酶，觀察兩組治療效果．結果：與治療前相比，兩組治療後尿蛋白、腎功能均有所改善（P〈0．05）；與對照組相比，觀察組患者上述指標改善更明顯（P〈0．05）．結論：蚓激酶治療IgA。腎病療效確切，且無嚴重不良反應．
목적：탐토인격매치료IgA신병（IgAN）적림상효과화안전성．방법：장30례재본원주원치료급문진치료적IgA신병환자수궤분위관찰조화대조조，대조조급여기출치료，관찰조재기출치료상가용인격매，관찰량조치료효과．결과：여치료전상비，량조치료후뇨단백、신공능균유소개선（P〈0．05）；여대조조상비，관찰조환자상술지표개선경명현（P〈0．05）．결론：인격매치료IgA。신병료효학절，차무엄중불량반응．
Objective: To investigate the clinical effect and safety of Lumbrokinase in treating IgA nephropathy. Methods: 30 cases of IgA nephropathy patients who underwent hospitalization treatment and outpatient treatment in our hospital, were randomly devided into observation group and control group. The control group were given basic treatment, but for the observation group, besides the basic treatment, plus Lumbrokinase. The therapeutic effects of two groups were observed. Results: Compared with before treatment, the proteinuria and kidney function in the two groups were ameliorated in different degree(P〈0.05); Compared with the control group, the above indexs of observation group were significantly ameliorated (P〈0.05).Conclusion: Lumbrokinase has a definite therapeutic effect on IgA nephropathy without severe adverse reactions.
